Academix vs CytoReason
Academix vs CytoReason, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Academix is on 16/100 and CytoReason on 68/100.
Where each one leads
Academix
- agent readiness: 31/100 against 21/100
CytoReason
- our overall score: 68/100 against 16/100
- domain rating: 40/100 against 2/100
- headcount: 116 against 2
- LinkedIn following: 12,830 against 171
At a glance
| Measure | Academix | CytoReason |
|---|---|---|
| What it is | AI-powered platform connecting industry R&D needs with academic researchers. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Knowledge, Biotech, HealthTech | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2017 | 2016 |
| Headquarters | Not published | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Academix | CytoReason |
|---|---|---|
| Employees | 2 | 116 |
| Headcount growthLast 12 months | Not published | +13.7% |
| Total funding | Not published | $128M |
| Latest round | Bootstrapped | Series B |
| LinkedIn followers | 171 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Academix | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 16/100 | 68/100 |
| Traction | 5/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | 29/100 | 30/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (31/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 2/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Academix | CytoReason |
|---|---|---|
| Analytics | Not detected | Segment |
Academix vs CytoReason: common questions
Which is better, Academix or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 16/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Academix and CytoReason compare on the numbers?
Academix leads on agent readiness (31/100 against 21/100). CytoReason leads on our overall score (68/100 against 16/100), domain rating (40/100 against 2/100), headcount (116 against 2), LinkedIn following (12,830 against 171).
Read the full Academix review and pricing or the CytoReason review and pricing. You can also browse other Academix alternatives we track.